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Abstract
Background: Inherited retinal dystrophies, including Retinitis Pigmentosa and Leber Congenital Amaurosis among
others, are a group of genetically heterogeneous disorders that lead to variable degrees of visual deficits. They can
be caused by mutations in over 100 genes and there is evidence for the presence of as yet unidentified genes in a
significant proportion of patients. We aimed at identifying a novel gene for an autosomal recessive form of early
onset severe retinal dystrophy in a patient carrying no previously described mutations in known genes.
Methods: An integrated strategy including homozygosity mapping and whole exome sequencing was used to
identify the responsible mutation. Functional tests were performed in the medaka fish (Oryzias latipes) model
organism to gain further insight into the pathogenic role of the ADAMTS18 gene in eye and central nervous system
(CNS) dysfunction.
Results: This study identified, in the analyzed patient, a homozygous missense mutation in the ADAMTS18 gene,
which was recently linked to Knobloch syndrome, a rare developmental disorder that affects the eye and the
occipital skull. In vivo gene knockdown performed in medaka fish confirmed both that the mutation has a
pathogenic role and that the inactivation of this gene has a deleterious effect on photoreceptor cell function.
Conclusion: This study reveals that mutations in the ADAMTS18 gene can cause a broad phenotypic spectrum of
eye disorders and contribute to shed further light on the complexity of retinal diseases.
Keywords: Inherited retinal dystrophies, ADAMTS18, Exome, Homozygosity mapping, Medaka fish, Knobloch
syndrome
Background
Inherited retinal dystrophies (IRD) are a genetically he-
terogeneous group of disorders that represent the most
frequent causes of genetic blindness in the western
world [1,2]. They include Retinitis Pigmentosa (RP) and
Leber Congenital Amaurosis (LCA), among the others.
RP is the most frequent form of retinal dystrophies with
an approximate incidence ranging between 1 in 3000
and 1 in 5000 individuals [1,3,4]. LCA is characterized
by a severe visual impairment that starts in the first
years of life [5]. Both RP and LCA are generally charac-
terized by a large extent of genetic heterogeneity. Over
the last few years, about 230 genes causing inherited ret-
inal diseases have been mapped to chromosomal loca-
tions (see RETnet web site: http://www.sph.uth.tmc.edu/
RetNet/) and about 190 responsible genes have been
identified. It is currently possible to determine the mo-
lecular defect underlying IRDs in up to 50% of patients
[6], which strongly indicates the existence of additional
genes responsible for these conditions.
We recently analyzed a cohort of over 400 Italian
patients with autosomal recessive retinal dystrophies,
including Retinitis Pigmentosa (ARRP) and LCA ([7]
and unpublished data). Patients were screened for the
presence of previously described mutations in genes with
a known pathogenic role in ARRP and LCA using
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genotyping microchips based on the allele-specific pri-
mer extension (APEX) technique [8]. About 70% of the
analyzed patients did not harbor any previously
described mutation in known LCA/ARRP genes. We
reasoned that this subset of patients could be a valuable
resource to identify novel retinal dystrophy genes.
Therefore, we selected a subset of the latter patients,
preferentially those with some evidence of belonging to
consanguineous families, for homozygosity mapping
genotyping followed by whole exome sequencing ana-
lysis, which has proven to be an effective strategy for the




We used standard methods to isolate genomic DNA
from peripheral blood of the patients and their family
members. Informed consent was obtained from all par-
ticipating patients and families according to the Decla-
ration of Helsinki and the studies were approved by the
Research Ethics Committee of the Second University of
Naples.
Ophthalmologic examination including best corrected
visual acuity using Snellen charts or Teller Acuity Cards,
measurement of objective refractive error after cyclople-
gia, slit-lamp biomicroscopy, dilated fundus examination,
bilateral full-field ERGs and optical coherence tomog-
raphy (OCT) recordings, was carried out as previously
described [11].
SNP genotyping
Genotyping was performed on SNP microarray (Gene-
Chip Genome-Wide Human SNP Array 5.0, Affymetrix,
Santa Clara, CA). Array experiments were performed
according to protocols provided by the manufacturer.
Genotypes were called with the Genotype Console pro-
gram, ver. 2.1 (Affymetrix) and regions of homozygosity
were identified using PLINK [12], with a sliding window
of 50 SNPs and allowing 2 heterozygous SNPs (miscalls)
and 10 missing SNPs (no calls) per window. Regions
containing more than 250 consecutive homozygous
SNPs were considered to be significant homozygous
regions, on average corresponding to a genomic size of 1
Megabase (Mb).
Whole exome sequencing
Whole exome enrichment was carried out using the Sur-
eSelect All Exon kit v.1 (Agilent Technologies, Santa
Clara, CA, USA) according to the manufacturer instruc-
tions. Whole exome sequencing was carried out on a
SOLiD 3 Plus System (Life Technologies, Carlsbad, CA,
USA). Sequencing reads were mapped to the reference
genome (UCSC, hg19 build) using the software BioScope
v1.3 (Life Technologies, Carlsbad, CA, USA). Single
nucleotide variations (SNV) and in-del mutation calling
analyses were carried out using the diBayes algorithm
with medium stringency settings and the SOLiD Small
Indel Fragment Tool, respectively.
RNA in situ hybridization and immunohistochemistry
RNA in situ hybridization on mouse sections and immu-
nohistochemistry experiments on medaka eyes were
performed according to previously published protocols
[13,14].
Medaka stocks and mRNA injections
The Cab-strain of wild type medaka fish were kept
and staged as described [15]. A morpholino (Mo;
Gene Tools LLC, Oregon, USA) was designed against
the ATG initiation codon and the 50 untranslated re-
gion of the medaka ortholog of the ADAMTS18 gene
(olAdamts18) whereas a control Mo carrying five mis-
matches (mmMo-Adamts18) was used as a control
(see sequences in Additional file 1: Table S2). The
specificity and inhibitory efficiencies of Mo-Adamts18
were determined as described in [16]. Mo-Adamts18
was injected at a 90 μM concentration into one
blastomere at the two-cell stage. In vitro synthesis of
the human wild type ADAMTS18 mRNAs as well as
of the c.T3235 > C mutated form was performed as
described [14]. Morpholino and mRNA injections
were carried out as previously described [14,17,18].
The light-induced photoreceptor cell degeneration
assay was performed as previously described [19].
Medaka embryos were incubated with phenyl thiourea
(PTU) to prevent pigmentation [18]. Fish were sacrificed
and analyzed after 5 days of constant light.
Results and discussion
Clinical features of patient A24
Among the selected patients, subject A24, a 30-year old
male, displayed a severe early-onset retinal dystrophy ac-
companied by an autistic disorder. He is the second and
last son of two parents that were born in the same small
community in Southern Italy. Delivery was at full term
without any complication and birth weight was 3750 g.
At the age of 2.5, he was diagnosed with autism charac-
terized by emotional indifference and poor/no response
to environmental stimuli. A brain CT scan performed at
that age was normal. At 2 years of age, the patient
started to display exotropia and nystagmus and visual
impairment, namely night blindness and reduced peri-
pheral vision. At the age of 5, following a full-field elec-
troretinogram recorded under sedation that showed
extinguished rod and cone responses, the patient
received a diagnosis of Early-Onset Severe Retinal Dys-
trophy [20-22]. At the age of 15, he underwent a more
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detailed ophthalmological evaluation that revealed a
hypermetropic refraction (Right Eye: + 2; Left Eye: + 3)
and a non-measurable visual acuity due to poor cooper-
ation. Ocular motility testing revealed the presence of
exotropia and nystagmus. No signs of fibrillar vitreous
condensation were observed by slit lamp analysis.
Fundus examination showed attenuated retinal vessels,
macular dystrophy, and diffuse mid-peripheral RPE
mottling with myriads of tiny white and black dots
(Figure 1A). During the follow-up examination at the
age of 21, his best corrected visual acuity was 20/1000
and full-field electroretinogram showed extinguished rod
and cone responses. At the age of 30, an incipient pos-
terior subcapsular cataract in the right eye was also
observed, while all other ocular defects were unchanged.
He underwent an OCT (Optical Coherence Tomog-
raphy) test that demonstrated an absence of foveal
depression due to the presence of macular pucker asso-
ciated with intraretinal cystoid spaces and partial vitre-
ous attachment to the optic disc (data not shown).
Complete physical evaluation failed to reveal involve-
ment of other organs and systems.
Identification of a mutation in the ADAMTS18 gene in
patient A24
We carried out SNP genotyping analysis on a genomic
DNA sample from patient A24. This analysis revealed
the presence of four large homozygous regions in the
genome of the patient, namely on chromosomes 8, 4,
3 and 16 for a total of 15.5 Mb (Additional file 2:
Table S1).
We then performed whole exome sequencing analysis
on patient A24. Over 65 million sequencing reads, corre-
sponding to about 3.3 Gigabases (Gb) of mappable
sequences were obtained using a SOLiD 3 Plus System
(Life Technologies, Carlsbad, CA, USA). In total, 86.12%
reads could be mapped to the reference genome (UCSC,
hg19 build). About 77% of the uniquely mapped reads
were aligned on the targeted exome after duplicate reads
removal, with 70% of the targeted exons covered at > 20x
Figure 1 The ADAMTS18 gene is mutated in a patient with Early Onset Severe Retinal Dystrophy. (A) Fundus examination of patient A24
revealed attenuated retinal vessels, macular dystrophy, and diffuse mid-peripheral RPE mottling with myriads of tiny white and black dots. (B)
Schematic representation, visualized with the Integrative Genomics Viewer (IGV) browser, of the mapped exome sequencing reads around the
ADAMTS18 c.T3235 > C sequence variant in patient A24. The upper part shows the wild-type sequence and the coverage per base. The c.T3235 >
C homozygous variant is shown in brown. Please note that the sequence variant shown in red corresponds to a described SNP (rs35478105). (C)
Validation by Sanger sequencing of the c.T3235 > C in patient A24 while his parents and his unaffected brother are heterozygous for the variation
(red arrows); the rs35478105 SNP is labeled by an asterisk. (D) The top diagram shows a schematic representation of the ADAMTS18 protein. The
c.T3235 > C (p.C1079R) variant affects a cysteine residue localized within the third TSP type 1 motifs, which is highly conserved across evolution
(red asterisk, bottom panel). (E) RNA in situ hybridization experiment showing that the murine Adamts18 is expressed in the adult mouse retina
(see text for further details). ON, optic nerve.
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depth. Overall, we identified 13.388 exonic variants
including 6.213 non-synonymous SNVs, 152 small inser-
tions or deletions, 71 stop-gain or stop-loss variants and
40 variants putatively affecting splice sites. Further filter-
ing based on the exclusion of all known dbSNP variants
(using dbSNP130) reduced the total number to 760 and
the application of an autosomal-recessive model of
inheritance for the disease left 110 sequence variants. By
limiting the analysis to the regions of homozygosity and
by only considering genes with reported evidence of
significant expression in the eye [23,24], we were left
with only a single homozygous missense variation,
namely c.T3235 > C (p.C1079R) in the ADAMTS18 gene
(NM_199355) that is localized to the long arm of
chromosome 16 (Figure 1B). Intriguingly, Aldahmesh
et al. recently reported a homozygous missense variation
[25] in this gene in a Saudi Arabian family with
Knobloch syndrome, a rare autosomal recessive develop-
mental disorder that affects the eye and the occipital
region of the skull and the brain (On-line Mendelian
Inheritance in Man (OMIM) #267750). They therefore
proposed ADAMTS18 as the gene responsible for
Knobloch syndrome even if they did not provide any
functional evidence in support of their hypothesis [25].
Due to the above-mentioned observations, we regarded
this gene as a good candidate for a pathogenic role in
the phenotype of patient A24 and therefore selected it
for further analysis. ADAMTS18 is a member of the
ADAMTS protein family, a family of metalloproteinases
similar to the ADAM proteins (A Disintegrin-like And
Metalloproteinase), but distinct by the additional presence
of ThromboSpondin (TSP) motifs in the C-terminus and
the lack of transmembrane domains [26]. The c.T3235 > C
mutation causes the substitution of a highly conserved
cysteine residue with an arginine in one of the four
C-terminal TSP type 1 motifs of the protein (Figure 1D),
which are known to be important in modulating
ADAMTS-mediated proteolysis [27] and influence protein
recognition and matrix localization [28].
Sanger sequencing confirmed that the c.T3235 > C
sequence variation was present in homozygosity in pa-
tient A24 (Figure 1C). The patient’s parents and his
healthy brother were found to be heterozygous carriers
of the mutation, which is in line with the autosomal
recessive inheritance of the disorder in the family
(Figure 1C). The variation was not present in neither
the Exome Variant Server (http://evs.gs.washington.
edu/EVS/) nor in over 350 Italian control DNA samples.
Finally, the c.T3235 > C variation was predicted to be
“disease causing” by MutationTaster (http://www.muta-
tiontaster.org/) with high probability and “probably
damaging” by Polyphen2 (http://genetics.bwh.harvard.
edu/pph2/index.shtml), further supporting its putative
pathogenic role.
This is the second report that describes a putative
pathogenic role of the ADAMTS18 gene in human ge-
netic diseases that affect the eye and the central nervous
system (CNS). Due to the recent description of another
ADAMTS18 homozygous missense mutation, i.e., the p.
S179L, in a family with Knobloch syndrome [25], we
carefully revised the clinical history and phenotype of
patient A24 to detect a possible overlap with the
Knobloch phenotype. However, the lack of any detec-
table occipital defect as well as the lack of myopia
(the patient is actually hypermetropic) and of the clas-
sical signs of vitreoretinal degeneration [29] prompted
us to exclude the diagnosis of Knobloch syndrome in
patient A24 (Figure 1A and data not shown) thus sug-
gesting that the ADAMTS18 gene is also responsible for
non-Knobloch forms of retinal diseases.
To determine whether mutations in ADAMTS18 are
more widely involved in retinal dystrophies, we analyzed
450 unrelated individuals who had ARRP, LCA or auto-
somal recessive Cone Rod dystrophy and who had
significant homozygous regions (see Methods). In 9 fa-
milies, ADAMTS18 was located in significantly large
homozygous regions: sequence analysis of probands
from these families, however, did not reveal the presence
of additional mutation in ADAMTS18.
ADAMTS18 is expressed in the adult eye
ADAMTS18 was previously reported to be expressed in
the developing mouse eye [25]. We aimed at determi-
ning whether ADAMTS18 is also expressed in the adult
eye, and mainly in the retina, i.e., the main target of the
phenotype present in patient A24. To that purpose, we
performed RT-PCR experiments on human retina cDNA
(Clontech). As a result, we detected the expected size
products (data not shown) using oligonucleotide pri-
mers specific for the ADAMTS18 mRNA sequence
(Additional file 1: Table S2) and we confirmed their
identity by Sanger sequencing. To define the sites of
expression of this gene at the cellular level, we per-
formed RNA in situ hybridization experiments on mu-
rine adult eye section collected at P60. This experiment
revealed the murine Adamts18 gene to be strongly
expressed in the retinal ganglion cell layer (GCL), in the
inner part of the inner nuclear layer (INL) and in the
retinal pigment epithelium (RPE) (Figure 1E).
In vivo analysis in medaka fish
To further prove the pathogenic effect of the
ADAMTS18 c.T3235 > C variation in patient A24, we
carried out an in vivo functional test in the Oryzias
latipes (medaka fish) model system by means of gene
knock-down and rescue assays, as already described [17].
We designed a specific morpholino oligonucleotide
against the ATG initiation codon and the 50 untranslated
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region of the medaka ortholog of the ADAMTS18 gene
(olAdamts18) (Additional file 1: Table S2) and we
injected it into fertilized one-cell embryos. We observed
an aberrant CNS phenotype at stage (st)40 in morphant
embryos (79 ± 3% of 1,300 injected embryos), particu-
larly in the telencephalic and mesencephalic areas
(Figure 2A-B”) of the brain. In particular, we observed
an altered morphology of the dorsolateral part of the te-
lencephalon (DLT in Figure 2B’) and a size reduction of
the telencephalic ventricles (TV in Figure 2B’). Further-
more, we observed an expansion of the optic tectum in
the mesencephalon (OT in Figure 2B”). Interestingly, the
areas of the medaka brain affected by the olAdamts18
knockdown correspond to the most posterior areas of
the human brain, which can be altered in Knobloch syn-
drome patients (OMIM #267750). The above-described
aberrant medaka phenotypes were significantly rescued
when the olAdamts18 morpholino was co-injected with
Figure 2 The c.T3235 > C ADAMTS18 mutation has a deleterious effect in vivo. Bright-field stereomicroscopy images of dorsal views of
control (A), Mo-AdamTS18- (B), MO-AdamTS18/ADAMTS18wt- (C), and MO-AdamTS18/ADAMTS18mut- (D) injected medaka embryos. (A’,A”,B’,B”,C’,
C”, D’,D”) Frontal cryostat sections of St40 medaka embryos stained with DAPI (white). Panels A’-D’ are frontal sections through the telencephalon
(the section plan is marked by the blue line), whereas panels A”-C” are frontal sections through the mesencephalon (the section plan is marked
by the red line). (B’) In Mo-AdamTS18-injected embryos, both the dorsolateral part of the telencephalon (DLT) and the size of the telencephalic
ventricles (TV) are altered with respect to control embryos (A’). (B”) Expansion of the optic tectum (OT) in the mesencephalon is present in Mo-
AdamTS18-injected embryos. (C’-C”) Wild-type human ADAMTS18 mRNA co-injection with Mo-AdamTS18 restores the correct pattern of both
telencephalic and mesencephalic tissue. (D’-D”) Co-injection of the human ADAMTS18 mRNA carrying the c.T3235 > C mutation with the Mo-
AdamTS18 does not rescue the telencephalic and mesencephalic phenotypes.
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the full-length coding human ADAMTS18 synthetic
mRNA (93 ± 2% of 600 injected embryos; Figure 2C-C”)
but not with the human mRNA carrying the c.T3235 > C
mutation (Figure 2D-D”). These data provide in vivo evi-
dence that the c.T3235 > C missense variation in the
ADAMTS18 gene has a pathogenic effect. We believe
that the in vivo gene knockdown/rescue assays in me-
daka can be used as a rapid and efficient tool to screen
the possible pathogenic role of sequence variants identi-
fied in the course of whole exome or whole genome
sequencing efforts in patients with genetic diseases,
particularly in those characterized by a developmental
phenotype.
We could not detect any gross morphological abnorma-
lity of the eye in morphant embryos until st40. Therefore,
in order to gain further insight into the involvement of
ADAMTS18 in retinal function in vertebrates, we decided
to perform a functional test in medaka fish. In particular,
we decided to use the light-induced photoreceptor dege-
neration model. In teleost fish, including medaka fish,
exposure of the retina to intense light is a noninvasive
method to elicit the selective degeneration of photorecep-
tors [30]. We carried out this test in st40 olAdamts18
knockdown embryos and we analyzed their retinas 5 days
later (post-hatching stage, n = 20 eyes). We observed a
notable increase of light-induced rod photoreceptor da-
mage in olAdamts18 knockdown vs. wild type fish, as
assessed by immunofluorescence analysis with an anti-
Rhodopsin antibody (Figure 3). In particular, we detected
a reduction of about 50% of the Rhodopsin-positive retinal
areas in Adamts18-deficient eyes as compared with wild-
type eyes, following light damage. These data strongly
indicate that ADAMTS18 is required for proper photo-
receptor function and further corroborate the pathogenic
role of this gene in inherited retinal dystrophies. The evi-
dence that this gene does not seem to be expressed in
Figure 3 Exposure to intense light induces a severe retinal degeneration in Mo-AdamTS18-injected medaka fish. Representative frontal
eye sections, immunostained with an anti-Rhodopsin antibody (green), from P5 control (A) and Mo-AdamTS18–injected (B) medaka fish after
5 days of constant light exposure. Sections are counterstained with DAPI (blue). We observed a significant reduction in both the thickness of the
photoreceptor outer segment (OS) and in the intensity of rhodopsin staining in Mo-AdamTS18–injected medaka fish as compared with control
animals following constant and intense light exposure. A’ and B’ are higher magnifications of the areas marked by the white dashed boxes in A
and B, respectively. Other abbreviations: ONL, Outer Nuclear Layer; INL, Inner Nuclear Layer. Scale bars, red lines: 20 μm.
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photoreceptors (Figure 1E) is not in contrast with the
above findings. ADAMTS18 is expressed in the RPE, a tis-
sue that plays a pathogenic role in many forms of retinal
disorders [31,32].
Conclusions
We determined, by using a multidisciplinary strategy
involving the use of advanced genomic procedures
and in vivo functional analysis, that mutations in the
ADAMTS18 gene, recently proposed to cause Knobloch
syndrome, can also be responsible, although with a rela-
tively low frequency, for early-onset severe retinal dys-
trophy possibly accompanied by other CNS features,
such as autism and neurodevelopmental delay. Impor-
tantly, the results of our ADAMTS18 knockdown experi-
ment in medaka provide for the first time in vivo
functional support to the pathogenic role of this gene in
Knobloch syndrome as well. Our data indicate that dif-
ferent mutations in the ADAMTS18 can be linked to the
pathogenesis of different eye disorders and contribute to
shed further light on the molecular mechanisms under-
lying the complexity of inherited retinal dystrophies.
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